Amoxycillin Clavulanate Acid tablets manufacturers and suppliers are producing an antibiotic combination that is effective against a variety of bacterial and viral infections. This tablet is available in the market in different potencies as per the intensity of infection. CAPICLAV-1000 is the best antibiotic medicine available on the market which has the composition of Amoxycillin 875 mg + Clavulanate Acid 125 mg.
Amoxycillin Clavulanate Acid tablets use
Amoxycillin and Clavulanic acid tablets are antibiotics that are useful in the treatment of bacterial infections of the lungs, sinus, blood, respiratory system, nose, throat and urinary tract infection. All these infections are treatable with an antibiotic line of treatment along with medications for infection symptoms.
Brand Name: CAPICLAV-1000
Composition: Amoxycillin 875 mg + Clavulanate Acid 125 mg
Amoxycillin is a penicillin antibiotic that stops the growth of infectious bacteria and prevents them from forming protective layers to shield them against antibiotics.
Similarly, Clavulanic acid increases the effect of amoxycillin and makes it effective for a longer time to treat the infection in the body. In combination, these two drugs are widely used to treat mild to moderate infections caused by various bacteria.
Pharma franchise business of antibiotic medicines
Antibiotic medicines are very common in India. These medicines are widely used to treat bacterial, viral and fungal infections. Nowadays, it is more often to see an increase in infections in public. Furthermore, we Indians have developed resistance against antibiotic medicines. This is why we need stronger doses to treat bacterial infections. This phenomenon creates a huge sales potential and demand for antibiotic medicines in the ground market.
In India, Casca Remedies is a pharma franchise company that manufactures an excellent range of antibiotics medicines. We also provide lucrative business opportunities in the franchise market to support new entrants. We welcome everyone to join this pharmaceutical industry and create a business around antibiotic medicines to capitalise on inflated demand and sales in the Indian market.
